arrow
F

Florian Kuchenbauer

british columbia cancer agency
H指数:38
被引数:7,902

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation

原癌基因miR-106a-363集群通过线粒体激活增强不良风险急性髓系白血病

LEUKEMIA
IF13.4
2025-03-170
PRE
Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNXI::RUNXITI

在携带RUNXI::RUNXITI的急性髓系白血病儿童中,诱导期间出现白血病相关的具有非典型免疫表型的嗜碱性粒细胞和肥大细胞,不应被解释为可测量的微小残留病。

BLOOD
IF23.1
2024-11-050
PRE
Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

真实世界回顾性队列中接受强化化疗的伴有骨髓增生异常相关改变(AML-MRC)的急性髓系白血病患者的生存结局

BLOOD
IF23.1
2024-11-050
PRE
Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis (vol 15, 2340, 2024)
2024-10-070
OAAI
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products

使用冷冻保存与新鲜造血祖细胞产品进行异基因干细胞移植的结果

2024-10-010
OAAI
Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis
2024-03-153
OAAI
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells
LEUKEMIA
IF13.4
2019-11-2513
PREAI
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (vol 24, pg 282, 2018)
2018-04-0113
OAAI
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

索拉非尼通过在FLT3-ITD-mutant白血病细胞中产生IL-15促进小鼠和人类的移植物抗白血病活性

2018-02-12236
OAAI
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia
2017-12-0712
OAAI